Glenmark Pharmaceuticals to study potential COVID-19 drug combination

Glenmark Pharmaceuticals to study potential COVID-19 drug combination The study will look to enroll 158 hospitalized patients of moderate COVID-19 in India, the company added.

No comments:

Post a Comment